Vektor Medical
San Diego, United States · Artificial Intelligence, Biotechnology, Healthcare
Vektor Medical is a pioneer in non-invasive, AI-based arrhythmia analysis technology, aiming to revolutionize arrhythmia care for millions affected by atrial fibrillation and other arrhythmias. Their flagship product, vMap, is an AI-based, non-invasive arrhythmia analysis tool designed to improve cardiac ablation outcomes, optimize workflows, and increase procedural efficiency.
Key facts
- Headquarters
- San Diego, United States
- Employees
- 42
- Industries
- Artificial Intelligence, Biotechnology, Healthcare
- Status
- Private
- Website
- vektormedical.com
- Company page
Recent activity at Vektor Medical
- : Vektor Medical Appoints Kelly Perez as Chief Financial Officer
- : Vektor Medical Launches vMap, an AI-Powered Data Analytics Tool for Cardiac Arrhythmia Treatment with 91% Accuracy.
- : Vektor Medical
- : Vektor Medical Secures $16 Million Series A Funding
- : Vektor Medical, Inc.
- : Vektor Medical, Inc.
- : Vektor Medical, Inc.
Vektor Medical funding history
| Date | Round | Amount |
|---|---|---|
| Feb 2024 | Venture | $28.9M |
| Feb 2024 | Series A | $16.0M |
| Nov 2019 | Seed | $3.6M |
| Jul 2018 | Pre-Seed | $11K |
| May 2018 | Pre-Seed | $12K |
Leadership
- Kalle Marsal, Director
- Robert Krummen, Director
- Alexander Monko, Executive Officer, Director
- Robert Krummen, Executive Officer, Director
- Alexander Monko, Executive Officer, Director
- Robert Krummen, Executive Officer, Director
- Alexander Monko, Executive Officer, Director
- Kelly Perez, Senior Vice President of Operations
- Lana Caron, Chief Business Development Officer
- Chris Villongco, Executive Officer
- Chris Villongco, Executive Officer
Verified email and direct lines for Vektor Medical’s decision-makers are on Fundz. See plans
Vektor Medical in the news
- Vektor Medical Secures CE Mark for vMap Bringing the Benefits of Non-Invasive Arrhythmia Mapping to Europe - Business Wire (Oct 07, 2025)
- Vektor Medical Announces New CPT Code for Novel Noninvasive Arrhythmia Analysis Using vMap - BioSpace (Oct 24, 2023)
- Vektor Medical's vMap™ Mapping System Reported as Feasible and Effective as Part of a Non-Invasive Workflow for Arrhythmia Management When Using Stereotactic Ablative Radiotherapy - BioSpace (Sep 09, 2021)
Companies similar to Vektor Medical
- AKASA · Artificial Intelligence, Biotechnology, Health Care, Health Diagnostics, Machine Learning, Medical
- C the Signs · Artificial Intelligence, Biotechnology, Health Care, Health Diagnostics, Machine Learning, Medical
- Renovaro · Artificial Intelligence, Biotechnology, Health Care, Health Diagnostics, Machine Learning, Medical
- Healthplus.ai · Artificial Intelligence, Biotechnology, Health Care, Health Diagnostics, Machine Learning, Medical
- Uncovr · Artificial Intelligence, Biotechnology, Health Care, Health Diagnostics, Machine Learning, Medical
About Vektor Medical: questions and answers
What does Vektor Medical do?
Vektor Medical is a pioneer in non-invasive, AI-based arrhythmia analysis technology, aiming to revolutionize arrhythmia care for millions affected by atrial fibrillation and other arrhythmias. Their flagship product, vMap, is an AI-based, non-invasive arrhythmia analysis tool designed to improve cardiac ablation outcomes, optimize workflows, and increase procedural efficiency.
Where is Vektor Medical headquartered?
Vektor Medical is headquartered in San Diego, United States.
How many employees does Vektor Medical have?
Vektor Medical has about 42 employees.
Has Vektor Medical raised funding?
Yes. Fundz has recorded 5 funding events for Vektor Medical. The most recent, $28.9M, was in Feb 2024.
Who leads Vektor Medical?
Kelly Perez is a Senior Vice President of Operations at Vektor Medical.
What is the latest news on Vektor Medical?
On Aug 27, 2025, Vektor Medical Appoints Kelly Perez as Chief Financial Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy